Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Gerald Hsu

Lymphoma · UCSF

View

Dr. Chadi Nabhan

Lymphoma · Ryght AI / USC

View

Dr. Mark Roschewski

Lymphoma · MSK

View

Dr. Jonathan Friedberg

Lymphoma · URMC

View

Dr. Matthew Matasar

Lymphoma · Rutgers Cancer Institute

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    MSDr. Maryam S. Yazdy

    Dr. Maryam S. Yazdy

    Hematology & Oncology · Lymphoma
    BeOne Medicines
    maryams

    Research

    FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas

    2024

    Via Clinical Cancer Research

    Research

    Minimal Residual Disease Data in Hematologic Malignancy Drug Applications and Labeling: An FDA Perspective

    2023

    Via Clinical Cancer Research

    Research

    Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience

    2022

    Via Clinical Lymphoma, Myeloma & Leukemia

    Research

    Burkitt Lymphoma International Prognostic Index

    2021

    Via Journal of Clinical Oncology

    Research

    Outcomes of Burkitt Lymphoma with Central Nervous System Involvement: Evidence from a Large Multicenter Cohort Study

    2021

    Via Haematologica

    Research

    Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy

    2020

    Via Clinical Cancer Research

    Research

    A Retrospective Comparison of Venetoclax Alone or in Combination with an Anti-CD20 Monoclonal Antibody in R/R CLL

    2019

    Via Blood Advances

    Research

    Targeting Biology in Non-Hodgkin Lymphoma

    2019

    Via Hematology/Oncology Clinics of North America

    Research

    Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia

    2019

    Via JAMA Network Open

    Research

    Determining the Sequence of Novel Therapies in the Treatment of Relapsed Hodgkin's Lymphoma

    2018

    Via Expert Review of Hematology

    Research

    Combinations or Sequences of Targeted Agents in CLL: Is the Whole Greater Than the Sum of Its Parts?

    2018

    Via Blood

    Research

    Current Challenges in the Management of Follicular Lymphoma

    2017

    Via International Journal of Hematologic Oncology

    Research

    Extended Follow-Up of Patients Treated With Bendamustine for Lymphoid Malignancies

    2017

    Via Clinical Lymphoma, Myeloma & Leukemia

    Research

    Impact of Obinutuzumab Alone and in Combination for Follicular Lymphoma

    2017

    Via Blood and Lymphatic Cancer: Targets and Therapy

    Research

    FDA Approval Summary Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas

    2024

    Via Clin Cancer Res